只有约30%的结直肠癌伴肝转移的患者能够接受同时切除肝脏转移病变的根治性治疗。由于原发肿瘤的病变程度以及患者合并症的存在,姑息性治疗是不可切除患者唯一的选择。在一些病例中姑息性治疗可以局部或是全身控制肿瘤,延长存活时间。由于技术的逐渐进步,新的姑息性治疗方法在临床试验中得到检测并随后进入临床实践。本文就多学科间进行结直肠癌肝转移姑息性治疗的决策制定进行分析和总结。 Only about 30% of patients with colorectal cancer with liver metastases are able to undergo radical treatment for concurrent removal of liver metastases. Due to the extent of primary tumor lesions and the presence of patient comorbidities, palliative treatment is the only option in unresectable patients. In some cases palliative treatment can locally or systemically control tumors and prolong survival. Due to the gradual progress of technology, new palliative treatment methods have been tested in clinical trials and subsequently entered clinical practice. This article analyzes and summarizes the multi-disciplinary decision-making on palliative treatment of colorectal cancer with liver metastases.